Therefore, the current bioinformatics analysis aimed to evaluate the expression level, prognostic value, and mutation status of the STAT family in HCC patients to screen candidate therapeutic targets for further pharmacological experiments. The gene discussed is SOAT1; the disease is hepatocellular carcinoma.